Effects of Ginkgo biloba extract (EGb 761) and quercetin on lipopolysaccharide-induced release of nitric oxide

被引:100
作者
Wadsworth, TL [1 ]
Koop, DR [1 ]
机构
[1] Oregon Hlth Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97201 USA
关键词
iNOS; EGb; 761; quercetin; MAPK; macrophage;
D O I
10.1016/S0009-2797(01)00208-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Administration of bacterial lipopolysaccharide (LPS) to laboratory animals and cultured macrophages is known to induce the production of nitric oxide (NO) from inducible nitric oxide synthase (iNOS). Here we show that pre-treatment with Ginkgo biloba extract (EGb 761) suppresses the in vivo production of NO (measured by the Griess reaction) after challenge with LPS. In order to begin to understand the mechanism of this inhibition, we evaluated in vitro effects of EGb 761 and its flavonoid component, quercetin, on LPS-treated RAW 264.7 macrophages. Pre-treatment with EGb 761 or quercetin dose-dependently inhibited NO release. Both substances scavenged NO generated from the decomposition of sodium nitroprusside. Western analysis showed that EGb 761 and quercetin inhibited LPS-induced levels of iNOS protein. Northern blotting demonstrated that EGb 761 and quercetin decreased LPS-induced iNOS mRNA levels without altering the half-life. Activation of mitogen activated protein kinases (MAPKs) and the redox-sensitive transcription factors, nuclear factor-kappaB (NF-kappaB) and activator protein 1 (AP-1) are key events in the signal transduction pathways mediating iNOS induction. In our studies, both EGb 761 and quercetin inhibited p38 MAPK activity, which is necessary for iNOS expression in LPS-stimulated RAW 264.7 macrophages. However, differences in the response of NF-kappaB, AP-1, and Jun N-terminal kinase/stress activated protein kinase (JNK/SAPK) and its downstream substrates to EGb 761 and quercetin suggest that quercetin is not the sole component responsible for the in vivo inhibition of LPS-induced iNOS activation by EGb 761. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:43 / 58
页数:16
相关论文
共 56 条
[1]   Specific inhibitors of p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways block inducible nitric oxide synthase and tumor necrosis factor accumulation in murine macrophages stimulated with lipopolysaccharide and interferon-γ [J].
Ajizian, SJ ;
English, BK ;
Meals, EA .
JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (04) :939-944
[2]   INVOLVEMENT OF TYROSINE KINASE IN THE INDUCTION OF CYCLOOXYGENASE AND NITRIC-OXIDE SYNTHASE BY ENDOTOXIN IN CULTURED-CELLS [J].
AKARASEREENONT, P ;
MITCHELL, JA ;
APPLETON, I ;
THIEMERMANN, C ;
VANE, JR .
BRITISH JOURNAL OF PHARMACOLOGY, 1994, 113 (04) :1522-1528
[3]  
Bhat NR, 1998, J NEUROSCI, V18, P1633
[4]   Both Erk and p38 kinases are necessary for cytokine gene transcription [J].
Carter, AB ;
Monick, MM ;
Hunninghake, GW .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1999, 20 (04) :751-758
[5]   Involvement of p38 mitogen-activated protein kinase in lipopolysaccharide-induced iNOS and COX-2 expression in J774 macrophages [J].
Chen, BC ;
Chen, YH ;
Lin, WW .
IMMUNOLOGY, 1999, 97 (01) :124-129
[6]  
Chen CC, 1999, MOL PHARMACOL, V55, P481
[7]   Oroxylin A inhibition of lipopolysaccharide-induced iNOS and COX 2 gene expression via suppression of nuclear factor-κB activation [J].
Chen, YC ;
Yang, LL ;
Lee, TJF .
BIOCHEMICAL PHARMACOLOGY, 2000, 59 (11) :1445-1457
[8]   Analysis of the cytokine-stimulated human inducible nitric oxide synthase (iNOS) gene: Characterization of differences between human and mouse iNOS promoters [J].
Chu, SC ;
Marks-Konczalik, J ;
Wu, HP ;
Banks, TC ;
Moss, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 248 (03) :871-878
[9]   Molecular mechanisms in the antiproliferative action of quercetin [J].
Csokay, B ;
Prajda, N ;
Weber, G ;
Olah, E .
LIFE SCIENCES, 1997, 60 (24) :2157-2163
[10]   Consumption of quercetin and kaempferol in free-living subjects eating a variety of diets [J].
deVries, JHM ;
Janssen, PLTMK ;
Hollman, PCH ;
vanStaveren, WA ;
Katan, MB .
CANCER LETTERS, 1997, 114 (1-2) :141-144